Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amisulpride (BARHEMSYS) (3 trials)
Schizophrenia (Phase 1)
Trials (3 total)
Trial APIs (1 total)